ultrasound pelvis ct pelvis and abdomen saline hysterography spinal and chest x-ray full blood...
TRANSCRIPT
Ultrasound pelvis CT pelvis and
abdomen Saline hysterography Spinal and Chest X-ray Full blood count Pap smear ectocervix Pap smear endocervix Coagulation profile Serum CA125
Renal function tests Liver function tests Blind endometrial
biopsy Office hysteroscopy TSH Serum FSH D&C uterus None of the above
Ultrasound pelvis Rarely of much value because 75% of patients on Tamoxifen for >12m have abnormal endometrial echo
This is due to microcystic change in the endometrium and proximal myometrium
However, 98% negative predictive value for Ca endometrium if the echo is < 5 mm
CT pelvis and abdomen
Not unless you (or the patient or the radiologist) are prepared to pay for it!
Saline hysterography
Of some use in the evaluation of Tamoxifen-affected endometrium
Of most use in the delineation of polyps
Doppler flow in the stalk of polyps also useful
Spinal and chest X-ray
Only is there is some other reason to suspect breast cancer secondaries
Full blood count Only if there has been substantial PV bleeding or there is clinical evidence of anaemia or blood dyscrasia
Pap smear ectocervix
Pap smear endocervix
Should be done if not previously done or overdue
Because the sqaumocolumnar junction retreats into the cervical canal postmenopause an endocervical sample is desirable
But this has poor diagnostic value for endometrial cancer
Coagulation profile No
Unless clinically indicated for other reasons
Serum CA125 No
Unless clinically indicated for other reasons
Renal function tests Liver function tests
No
Unless clinically indicated for other reasons
Blind endometrial biopsy e.g. Pipelle
Tamoxifen is oestrogenic to the endometrium
And has a 0.2 – 4.0% risk of causing endometrial cancer
This is usually a diffuse endometrial disease
And can be excluded with >98% certainty by a blind endometrial sampling
Outpatient hysteroscopy
With or without directed biopsy is the procedure of choice for this patient
Uterine D&C A 21st century gynaecologist would favour ultrasound + Pipelle sampling or office hysteroscopy
TSH No
Unless clinically indicated for other reasons
FSH No
No tests 5 – 10 % of patients with postmenopausal bleeding have an endometrial cancer
And this patient on Tamoxifen is at increased risk
She will not be happy if you miss this, her second, brush with cancer
Do nothing It is rare for the cervix to be “closed” when an endometrial cancer is present
If the endometrial echo was <5 mm on ultrasound this would be a reasonable option
Uterine D&C with general anaesthesia
A reasonable option to exclude endometrial cancer
It is not 100% diagnostic
And re evaluation of the patient is desirable if the symptoms persist or
There are other grounds for suspicion
Re attempt after:
Vagifem for 7 days PV
Then 1000 ug Misoprostol the night before
A good option
Hysterectomy Unnecessarily aggressive
Unless there are other grounds for suspicion